Keeping you up to date on recent developments in diagnostics, including: Diagnosing fatty liver disease; Assessing COVID-19 with lung ultrasound; Noncoding mutations contribute to heart disease.
Keeping you up to date on recent developments in orthopedics, including: Buzzing to rebuild broken bone; Tiny mineral particles are better vehicles for promising gene therapy; New trial results question standard treatment plan for rheumatoid arthritis.
Keeping you up to date on recent developments in oncology, including: Researchers float ChIA PET as answer to prostate cancer puzzle; Dana-Farber offers liquid biopsy for renal cell carcinoma; Inhaled indocyanine green may enable lung tumor margin depiction.
A large epidemiological study published in the July 6, 2020, advance online issue of The Lancet found that most individuals who became infected with SARS-CoV-2 developed antibodies to the virus, confirming that infection usually results in at least a short-term immune response.
Keeping you up to date on recent developments in cardiology, including: Potassium channel distancing fights stroke; Examining ischemic stroke in patients with COVID-19 vs. those with influenza; COVID-19 infects heart cells in lab dish.
Keeping you up to date on recent developments in diagnostics, including: Broad scale genomic testing for childhood illness; Deep learning model for cancer prognosis; Placenta attachment theory.
Keeping you up to date on recent developments in orthopedics, including: New plastic biomaterials could lead to tougher, more versatile medical implants; A data treasure for gait analysis; Traditional strength training vs jump training for physically inactive young adults.
Keeping you up to date on recent developments in oncology, including: New microfluidic platform enables deeper analysis of role of angiogenesis in cancer; P53 'glue' gums up cancer cells; New blood test could aid in hepatocellular carcinoma screening.
Two separate groups have recently shown that in mouse models, inactivation of a single gene was enough to directly convert other cell types in the brain into neurons.
Chinese scientists at Peking University (PKU) in Beijing have developed a new in vitro patient-derived tumor-like cluster (PTC) model, which predicted the outcomes of neoadjuvant and conventional chemotherapies in colon, gastric and breast cancer patients, with a clinical consistency of >93%.
RSS
